Zoetis Inc. (NYSE:ZTS) Shares Purchased by Atomi Financial Group Inc.

Atomi Financial Group Inc. grew its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 10.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 6,651 shares of the company’s stock after purchasing an additional 626 shares during the period. Atomi Financial Group Inc.’s holdings in Zoetis were worth $1,084,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Clear Harbor Asset Management LLC lifted its holdings in Zoetis by 0.3% in the fourth quarter. Clear Harbor Asset Management LLC now owns 26,404 shares of the company’s stock worth $4,302,000 after acquiring an additional 75 shares during the last quarter. Segment Wealth Management LLC raised its position in shares of Zoetis by 0.9% during the 4th quarter. Segment Wealth Management LLC now owns 75,320 shares of the company’s stock worth $12,272,000 after purchasing an additional 654 shares during the period. Crossmark Global Holdings Inc. lifted its holdings in shares of Zoetis by 13.0% in the 4th quarter. Crossmark Global Holdings Inc. now owns 36,936 shares of the company’s stock worth $6,018,000 after purchasing an additional 4,248 shares during the last quarter. Ballentine Partners LLC boosted its position in Zoetis by 3.0% during the 4th quarter. Ballentine Partners LLC now owns 12,151 shares of the company’s stock valued at $1,980,000 after purchasing an additional 357 shares during the period. Finally, Martel Wealth Advisors Inc bought a new position in Zoetis during the 4th quarter worth $489,000. 92.80% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on ZTS. Stifel Nicolaus reduced their price target on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a report on Tuesday, January 7th. Leerink Partnrs upgraded shares of Zoetis to a “strong-buy” rating in a research report on Monday, December 2nd. JPMorgan Chase & Co. lifted their price target on Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a report on Friday, October 11th. UBS Group began coverage on Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price objective for the company. Finally, Leerink Partners began coverage on Zoetis in a research note on Monday, December 2nd. They set an “outperform” rating and a $215.00 target price on the stock. One research analyst has rated the stock with a hold rating, nine have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, Zoetis currently has an average rating of “Buy” and an average target price of $211.89.

Zoetis Price Performance

NYSE:ZTS opened at $166.64 on Thursday. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. The business’s 50-day moving average price is $170.60 and its 200 day moving average price is $179.89. Zoetis Inc. has a 52-week low of $144.80 and a 52-week high of $200.53. The firm has a market cap of $75.18 billion, a P/E ratio of 31.32, a PEG ratio of 2.55 and a beta of 0.89.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.12. The company had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The business’s revenue was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.36 EPS. As a group, sell-side analysts predict that Zoetis Inc. will post 5.9 earnings per share for the current fiscal year.

Zoetis Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 4th. Stockholders of record on Tuesday, January 21st will be paid a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This is a positive change from Zoetis’s previous quarterly dividend of $0.43. This represents a $2.00 annualized dividend and a dividend yield of 1.20%. Zoetis’s dividend payout ratio (DPR) is currently 32.52%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.